Burrill Report: Biotech Innovation Gets the Cash
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
Poor regulations and substandard use could be to blame for growing resistance to a leading anti-malaria drug, researchers say.
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
Copyright © 2024 | WordPress Theme by MH Themes